An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Phase of Trial: Phase IV
Latest Information Update: 06 Aug 2018
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 26 Jul 2018 Status changed from active, no longer recruiting to completed.
- 08 May 2018 Planned End Date changed from 25 Jun 2018 to 30 Jul 2018.
- 08 May 2018 Planned primary completion date changed from 25 Jun 2018 to 11 Jun 2018.